BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32323442)

  • 1. Association of eszopiclone, zaleplon, or zolpidem with complex sleep behaviors resulting in serious injuries, including death.
    Harbourt K; Nevo ON; Zhang R; Chan V; Croteau D
    Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):684-691. PubMed ID: 32323442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Z-drugs and risk for falls and fractures in older adults-a systematic review and meta-analysis.
    Treves N; Perlman A; Kolenberg Geron L; Asaly A; Matok I
    Age Ageing; 2018 Mar; 47(2):201-208. PubMed ID: 29077902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Z-drugs and Falls: A Focused Review of the Literature.
    Ryba N; Rainess R
    Sr Care Pharm; 2020 Dec; 35(12):549-554. PubMed ID: 33258763
    [No Abstract]   [Full Text] [Related]  

  • 4. Common Insomnia Drugs Receive Black Box Warning.
    Aschenbrenner DS
    Am J Nurs; 2019 Aug; 119(8):22. PubMed ID: 31356323
    [No Abstract]   [Full Text] [Related]  

  • 5. Nonbenzodiazepine Sedative Hypnotics and Risk of Fall-Related Injury.
    Tom SE; Wickwire EM; Park Y; Albrecht JS
    Sleep; 2016 May; 39(5):1009-14. PubMed ID: 26943470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients' Knowledge of Key Messaging in Drug Safety Communications for Zolpidem and Eszopiclone: A National Survey.
    Kesselheim AS; Sinha MS; Rausch P; Lu Z; Tessema FA; Lappin BM; Zhou EH; Dal Pan GJ; Zwanziger L; Ramanadham A; Loughlin A; Enger C; Avorn J; Campbell EG
    J Law Med Ethics; 2019 Sep; 47(3):430-441. PubMed ID: 31560634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sedative Hypnotics and the Risk of Falls and Fractures in the Elderly.
    Andrade C
    J Clin Psychiatry; 2018; 79(3):. PubMed ID: 29873951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zolpidem ingestion, automatisms, and sleep driving: a clinical and legal case series.
    Poceta JS
    J Clin Sleep Med; 2011 Dec; 7(6):632-8. PubMed ID: 22171202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of zolpidem and zaleplon on cognitive performance after emergent morning awakenings at Tmax: a randomized placebo-controlled trial.
    Dinges DF; Basner M; Ecker AJ; Baskin P; Johnston SL
    Sleep; 2019 Mar; 42(3):. PubMed ID: 30576525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drugs for Insomnia.
    Med Lett Drugs Ther; 2015 Jul; 57(1472):95-8. PubMed ID: 26147892
    [No Abstract]   [Full Text] [Related]  

  • 11. A double-blind, randomized, comparative study to evaluate the efficacy and safety of zaleplon versus zolpidem in shortening sleep latency in primary insomnia.
    Huang YS; Hsu SC; Liu SI; Chen CK
    Chang Gung Med J; 2011; 34(1):50-6. PubMed ID: 21392474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acute cognitive effects of zopiclone, zolpidem, zaleplon, and eszopiclone: a systematic review and meta-analysis.
    Stranks EK; Crowe SF
    J Clin Exp Neuropsychol; 2014; 36(7):691-700. PubMed ID: 24931450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group.
    Elie R; RĂ¼ther E; Farr I; Emilien G; Salinas E
    J Clin Psychiatry; 1999 Aug; 60(8):536-44. PubMed ID: 10485636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse Events Due to Insomnia Drugs Reported in a Regulatory Database and Online Patient Reviews: Comparative Study.
    Borchert JS; Wang B; Ramzanali M; Stein AB; Malaiyandi LM; Dineley KE
    J Med Internet Res; 2019 Nov; 21(11):e13371. PubMed ID: 31702558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In the Zzz zone: the effects of Z-drugs on human performance and driving.
    Gunja N
    J Med Toxicol; 2013 Jun; 9(2):163-71. PubMed ID: 23456542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the prescribing practices of nonbenzodiazepine, benzodiazepine receptor agonist hypnotics in adults at a federally qualified health center.
    Gray E; Bradley B
    J Am Pharm Assoc (2003); 2019; 59(4S):S146-S150. PubMed ID: 31248847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Insight into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions.
    Schifano F; Chiappini S; Corkery JM; Guirguis A
    Int J Neuropsychopharmacol; 2019 Apr; 22(4):270-277. PubMed ID: 30722037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse effects of Z-drugs for sleep disturbance in people living with dementia: a population-based cohort study.
    Richardson K; Loke YK; Fox C; Maidment I; Howard R; Steel N; Arthur A; Boyd PJ; Aldus C; Ballard C; Savva GM
    BMC Med; 2020 Nov; 18(1):351. PubMed ID: 33228664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unexpected effect of Zolpidem in a patient with attention deficit hyperactivity disorder.
    Furuhashi Y
    Asian J Psychiatr; 2019 Aug; 44():68-69. PubMed ID: 31325762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zolpidem-Associated Consequences: An Updated Literature Review With Case Reports.
    Westermeyer J; Carr TM
    J Nerv Ment Dis; 2020 Jan; 208(1):28-32. PubMed ID: 31834190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.